Premature Lungs
9
4
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Physiological Phenotyping of Respiratory Outcomes in Infants Born Premature
Early Caffeine and LISA Compared to Caffeine and CPAP in Preterm Infants
Relationship Between EIT and Respiratory Status in Very Preterm Infants
Baby ABS (Abdominal Binder Study)
Clinical Trial for the Evaluation of Customized 3D Printed NIV Nasal Masks in Premature Infants
Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS
Effect of Nasal CPAP Versus NIPPV On Diaphragm Electrical Activity (Edi) In VLBW Preterm Infants
Vibroacoustic Study of Lung Development in Newborn Infants
Comparison of Two Strategies for Surfactant Prophylaxis in Premature Infants